{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T12:40:27Z","timestamp":1741610427955,"version":"3.38.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Medical Science Research Project of Hebei","award":["20241298"],"award-info":[{"award-number":["20241298"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"DOI":"10.1186\/s12920-025-02115-6","type":"journal-article","created":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T11:41:31Z","timestamp":1741606891000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of CYP19 gene SNPs (rs7176005 and rs6493497) with polycystic ovary syndrome susceptibility in Northern Chinese women"],"prefix":"10.1186","volume":"18","author":[{"given":"Ya-li","family":"Hao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-miao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong-miao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-nan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-shuang","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,10]]},"reference":[{"issue":"6","key":"2115_CR1","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1093\/humupd\/dmy022","volume":"24","author":"MA Skiba","year":"2018","unstructured":"Skiba MA, Islam RM, Bell RJ, et al. Understanding variation in prevalence estimates of polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2018;24(6):694\u2013709.","journal-title":"Hum Reprod Update"},{"issue":"5","key":"2115_CR2","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1080\/09513590.2020.1859474","volume":"37","author":"F Ramezani Tehrani","year":"2021","unstructured":"Ramezani Tehrani F, Behboudi-Gandevani S, Bidhendi Yarandi R, et al. Prevalence of acne vulgaris among women with polycystic ovary syndrome: a systemic review and meta-analysis. Gynecol Endocrinol. 2021;37(5):392\u2013405.","journal-title":"Gynecol Endocrinol"},{"issue":"1","key":"2115_CR3","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s12920-022-01301-0","volume":"15","author":"XY Ma","year":"2022","unstructured":"Ma XY, Wang Z, Zhang CM, et al. Association of SNPs in the FK\u2013506 binding protein (FKBP5) gene among Han Chinese women with polycystic ovary syndrome. BMC Med Genomics. 2022;15(1):149.","journal-title":"BMC Med Genomics"},{"issue":"6","key":"2115_CR4","doi-asserted-by":"publisher","first-page":"2872","DOI":"10.3390\/ijms22062872","volume":"22","author":"AJH Albaghdadi","year":"2021","unstructured":"Albaghdadi AJH, Kan FWK. Therapeutic potentials of low-dose tacrolimus for aberrant endometrial features in polycystic ovary syndrome. Int J Mol Sci. 2021;22(6):2872.","journal-title":"Int J Mol Sci"},{"key":"2115_CR5","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.jpeds.2021.01.018","volume":"232","author":"FF Zhang","year":"2021","unstructured":"Zhang FF, Zhang Q, Wang YL, et al. Intergenerational inffuences between maternal polycystic ovary syndrome and offspring: an updated overview. J Pediatr. 2021;232:272\u201381.","journal-title":"J Pediatr"},{"issue":"1","key":"2115_CR6","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s13058-024-01923-5","volume":"26","author":"KX Bi","year":"2024","unstructured":"Bi KX, Chen MR, Zhao QR, et al. The shared genetic landscape of polycystic ovary syndrome and breast cancer: convergence on ER\u2009+\u2009breast cancer but not ER- breast cancer. Breast Cancer Res. 2024;26(1):161.","journal-title":"Breast Cancer Res"},{"issue":"1","key":"2115_CR7","first-page":"719050","volume":"1","author":"J Rojas","year":"2014","unstructured":"Rojas J, Chavez M, Olivar L, et al. Polycystic ovary syndrome, insulin resistance, and obesity: navigating the pathophysiologic labyrinth. Int J Reprod Med. 2014;1(1):719050.","journal-title":"Int J Reprod Med"},{"issue":"8","key":"2115_CR8","doi-asserted-by":"publisher","first-page":"945","DOI":"10.4103\/0366-6999.229899","volume":"131","author":"Y Zou","year":"2018","unstructured":"Zou Y, Zhu FF, Fang CY, et al. Identification of potential biomarkers for urine metabolomics of polycystic ovary syndrome based on gas chromatography-mass spectrometry. Chin Med J. 2018;131(8):945\u20139.","journal-title":"Chin Med J"},{"issue":"22","key":"2115_CR9","doi-asserted-by":"publisher","first-page":"3916","DOI":"10.3390\/nu16223916","volume":"16","author":"GD Martinez","year":"2024","unstructured":"Martinez GD, Vidal CS, Palacios I, et al. Effectiveness of probiotics, prebiotics, and synbiotics in managing insulin resistance and hormonal imbalance in women with polycystic ovary syndrome (PCOS): A systematic review of randomized clinical trials. Nutrients. 2024;16(22):3916.","journal-title":"Nutrients"},{"issue":"2","key":"2115_CR10","doi-asserted-by":"publisher","first-page":"583","DOI":"10.3390\/ijms23020583","volume":"23","author":"HM Sadeghi","year":"2022","unstructured":"Sadeghi HM, Adeli I, Calina D, et al. Polycystic ovary syndrome: A comprehensive review of pathogenesis, management, and drug repurposing. Int J Mol Sci. 2022;23(2):583.","journal-title":"Int J Mol Sci"},{"key":"2115_CR11","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1093\/humupd\/dmaa029","volume":"26","author":"V Wekker","year":"2020","unstructured":"Wekker V, van Dammen L, Koning A, et al. Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis. Hum Reprod Update. 2020;26:942\u201360.","journal-title":"Hum Reprod Update"},{"key":"2115_CR12","doi-asserted-by":"publisher","first-page":"491","DOI":"10.29252\/ijrm.15.8.491","volume":"15","author":"A Mehdizadeh","year":"2017","unstructured":"Mehdizadeh A, Kalantar SM, Sheikhha MH, et al. Association of SNP rs2414096 CYP19 gene with polycystic ovarian syndrome in Iranian women. IJRM. 2017;15:491\u20136.","journal-title":"IJRM"},{"issue":"6","key":"2115_CR13","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1007\/s10695-023-01270-w","volume":"49","author":"R Chaube","year":"2023","unstructured":"Chaube R, Sharma S, Joy K. Kisspeptin modulation of nonapeptide and cytochrome P450 aromatase mRNA expression in the brain and ovary of the catfish Heteropneustes fossilis: in vivo and in vitro studies. Fish Physiol Biochem. 2023;49(6):1489\u2013509.","journal-title":"Fish Physiol Biochem"},{"issue":"2","key":"2115_CR14","first-page":"1283","volume":"6","author":"KR Reddy","year":"2015","unstructured":"Reddy KR, Deepika MLN, Latha KP, et al. Polycystic ovary syndrome: role of aromatase gene variants in South Indian women. Int J Pharm Bio Sci. 2015;6(2):1283\u201396.","journal-title":"Int J Pharm Bio Sci"},{"key":"2115_CR15","first-page":"1","volume":"4","author":"RA Mostafa","year":"2016","unstructured":"Mostafa RA, Al-Sherbeeny MM, Abdelazim IA, et al. Relation between aromatase gene CYP19 variation and hyperandrogenism in polycystic ovary syndrome Egyptian women. J Infertil Reprod Biol. 2016;4:1\u20135.","journal-title":"J Infertil Reprod Biol"},{"key":"2115_CR16","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13048-015-0139-1","volume":"8","author":"J Chen","year":"2015","unstructured":"Chen J, Shen S, Tan Y, et al. The correlation of aromatase activity and obesity in women with or without polycystic ovary syndrome. J Ovarian Res. 2015;8:11.","journal-title":"J Ovarian Res"},{"key":"2115_CR17","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.amjmed.2006.07.003","volume":"119","author":"M Sowers","year":"2006","unstructured":"Sowers M, Wilson A, Kardia S, et al. Aromatase gene (CYP 19) polymorphisms and endogenous androgen concentrations in a multiracial\/multiethnic, multisite study of women at midlife. Am J Med. 2006;119:23\u201330.","journal-title":"Am J Med"},{"key":"2115_CR18","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jsbmb.2010.11.003","volume":"125","author":"M Akhtar","year":"2011","unstructured":"Akhtar M, Wright JN, Lee-Robichaud P. A review of mechanistic studies on aromatase (CYP19) and 17\u03b1-hydroxylase-17, 20-lyase (CYP17). J Steroid Biochem Mol Biol. 2011;125:2\u201312.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2115_CR19","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/bs.mie.2023.04.025","volume":"689","author":"D Ghosh","year":"2023","unstructured":"Ghosh D. Aromatase and steroid sulfatase from human placenta. Methods Enzymol. 2023;689:67\u201386.","journal-title":"Methods Enzymol"},{"key":"2115_CR20","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1093\/humrep\/deh900","volume":"20","author":"CJ Petry","year":"2005","unstructured":"Petry CJ, Ong KK, Michelmore KF, et al. Association of aromatase (CYP 19) gene variation with features of hyperandrogenism in two populations of young women. Hum Reprod. 2005;20:1837\u201343.","journal-title":"Hum Reprod"},{"key":"2115_CR21","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1159\/000339317","volume":"74","author":"PS Maier","year":"2012","unstructured":"Maier PS, Spritzer PM. Aromatase gene polymorphism does not influence clinical phenotype and response to oral contraceptive pills in polycystic ovary syndrome women. Gynecol Obstet Invest. 2012;74:136\u201342.","journal-title":"Gynecol Obstet Invest"},{"issue":"3\u20135","key":"2115_CR22","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S0960-0760(03)00359-5","volume":"86","author":"SE Bulun","year":"2003","unstructured":"Bulun SE, Sebastian S, Takayama K, et al. The human CYP19 (aromatase P450) gene: update on physiologic roles and genomic organization of promoters. J Steroid Biochem Mol Biol. 2003;86(3\u20135):219\u201324.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"10","key":"2115_CR23","doi-asserted-by":"publisher","first-page":"4600","DOI":"10.1210\/jcem.86.10.7947","volume":"86","author":"S Sebastian","year":"2001","unstructured":"Sebastian S, Bulun SE. A highly complex organization of the regulatory region of the human CYP19 (aromatase) gene revealed by the human genome project. J Clin Endocrinol Metab. 2001;86(10):4600\u20132.","journal-title":"J Clin Endocrinol Metab"},{"key":"2115_CR24","doi-asserted-by":"crossref","unstructured":"Revised. 2003 consensus. On diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004; 81(1):19\u201325.","DOI":"10.1016\/j.fertnstert.2003.10.004"},{"key":"2115_CR25","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.mefs.2017.05.007","volume":"22","author":"RV Bharathi","year":"2017","unstructured":"Bharathi RV, Swetha S, Neerajaa J, et al. An epidemiological survey: effect of predisposing factors for PCOS in Indian urban and rural population. Middle East Fertil Soc J. 2017;22:313\u20136.","journal-title":"Middle East Fertil Soc J"},{"key":"2115_CR26","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1007\/s10815-018-1162-0","volume":"35","author":"R Kaur","year":"2018","unstructured":"Kaur R, Kaur T, Kaur A. Genetic association study from North India to analyze association of CYP19A1 and CYP17A1 with polycystic ovary syndrome. J Assist Reprod Genet. 2018;35:1123\u20139.","journal-title":"J Assist Reprod Genet"},{"key":"2115_CR27","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.amjmed.2006.07.003","volume":"119","author":"MR Sowers","year":"2006","unstructured":"Sowers MR, Wilson AL, Kardia SR, et al. Aromatase gene (CYP19) polymorphisms and endogenous androgen concentrations in a multiracial\/multiethnic, multisite study of women at midlife. Am J Med. 2006;119:23\u201330.","journal-title":"Am J Med"},{"issue":"15","key":"2115_CR28","doi-asserted-by":"publisher","first-page":"15414","DOI":"10.18632\/aging.103602","volume":"12","author":"X Huang","year":"2020","unstructured":"Huang X, Wu B, Chen M, et al. Depletion of Exosomal circldlr in follicle fluid derepresses miR-1294 function and inhibits estradiol production via CYP19A1 in polycystic ovary syndrome [J]. Aging. 2020;12(15):15414\u201335.","journal-title":"Aging"},{"issue":"1","key":"2115_CR29","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1158\/0008-5472.CAN-09-3224","volume":"70","author":"L Wang","year":"2010","unstructured":"Wang L, Ellsworth KA, Moon I, et al. Functional genetic polymorphisms in the aromatase gene CYP19 vary the response of breast cancer patients to neoadjuvant therapy with aromatase inhibitors. Cancer Res. 2010;70(1):319\u201328.","journal-title":"Cancer Res"},{"issue":"1","key":"2115_CR30","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s13048-021-00879-w","volume":"14","author":"H Chaudhary","year":"2021","unstructured":"Chaudhary H, Patel J, Jain NK, et al. The role of polymorphism in various potential genes on polycystic ovary syndrome susceptibility and pathogenesis. J Ovarian Res. 2021;14(1):125.","journal-title":"J Ovarian Res"},{"issue":"9","key":"2115_CR31","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1007\/s43032-020-00375-4","volume":"28","author":"T Castillo-Higuera","year":"2021","unstructured":"Castillo-Higuera T, Alarc\u00f3n-Granados MC, Marin-Suarez J, et al. A comprehensive overview of common polymorphic variants in genes related to polycystic ovary syndrome. REPROD SCI. 2021;28(9):2399\u2013412.","journal-title":"REPROD SCI"},{"key":"2115_CR32","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/1471-2350-10-139","volume":"10","author":"JL Jin","year":"2009","unstructured":"Jin JL, Sun J, Ge HJ, et al. Association between CYP19 gene SNP rs2414096 polymorphism and polycystic ovary syndrome in Chinese women. BMC Med Genet. 2009;10:139\u201343.","journal-title":"BMC Med Genet"},{"issue":"1","key":"2115_CR33","doi-asserted-by":"publisher","first-page":"12942","DOI":"10.1038\/s41598-021-92265-1","volume":"11","author":"S Ashraf","year":"2021","unstructured":"Ashraf S, Rasool SUA, Nabi M, et al. Impact of rs2414096 polymorphism of CYP19 gene on susceptibility of polycystic ovary syndrome and hyperandrogenism in Kashmiri women [J]. Sci Rep. 2021;11(1):12942.","journal-title":"Sci Rep"},{"issue":"9","key":"2115_CR34","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1016\/j.amjmed.2006.07.003","volume":"119","author":"MR Sowers","year":"2006","unstructured":"Sowers MR, Wilson AL, Kardia SR, et al. Aromatase gene (CYP 19) polymorphisms and endogenous androgen concentrations in a multiracial\/multiethnic, multisite study of women at midlife. Am J Med. 2006;119(9):S23\u201330.","journal-title":"Am J Med"},{"issue":"3","key":"2115_CR35","first-page":"272","volume":"13","author":"AR Al-Salihi","year":"2015","unstructured":"Al-Salihi AR, Hamdan FB, Mutib MT. Effect of CYP19 gene on polycystic ovary syndrome phenotype in Iraqi women. Iraqi J Med Sci. 2015;13(3):272\u20138.","journal-title":"Iraqi J Med Sci"},{"issue":"1","key":"2115_CR36","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s43141-023-00540-7","volume":"21","author":"P Hegde","year":"2023","unstructured":"Hegde P, Shetty SS, Shetty PK, et al. Delineating the role of single-nucleotide polymorphism of CYP19 gene on aromatase activity in South Indian women with polycystic ovary syndrome. J Genet Eng Biotechnol. 2023;21(1):87.","journal-title":"J Genet Eng Biotechnol"},{"issue":"5","key":"2115_CR37","doi-asserted-by":"publisher","first-page":"478","DOI":"10.3109\/09513590.2013.774359","volume":"29","author":"N Leandros Lazaros","year":"2013","unstructured":"Leandros Lazaros N, Xita E, Hatzi, et al. CYP19 gene variants affect the assisted reproduction outcome of women with polycystic ovary syndrome. Gynecol Endocrinol. 2013;29(5):478\u201382.","journal-title":"Gynecol Endocrinol"},{"issue":"8","key":"2115_CR38","doi-asserted-by":"publisher","first-page":"5041","DOI":"10.1007\/s11033-013-2605-4","volume":"40","author":"P Xu","year":"2013","unstructured":"Xu P, Zhang XL, Xie GB, et al. The (TTTA)n polymorphism in intron 4 of CYP19 and the polycystic ovary syndrome risk in a Chinese population. Mol Biol Rep. 2013;40(8):5041\u20137.","journal-title":"Mol Biol Rep"},{"issue":"1","key":"2115_CR39","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1158\/0008-5472.CAN-09-3224","volume":"70","author":"L Wang","year":"2010","unstructured":"Wang L, Ellsworth KA, Moon I, et al. Functional genetic polymorphisms in the aromatase gene CYP19 vary the response of breast cancer patients to neoadjuvant therapy with aromatase inhibitors. CABCER RES. 2010;70(1):319\u201328.","journal-title":"CABCER RES"},{"issue":"3","key":"2115_CR40","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1159\/000433597","volume":"231","author":"WL Rui","year":"2015","unstructured":"Rui WL, Sheng YY, Hu RM, et al. Association of single nucleotide polymorphisms in the CYP19A1 gene with female pattern hair loss in a Chinese population. Dermatology. 2015;231(3):239\u201344.","journal-title":"Dermatology"},{"issue":"3","key":"2115_CR41","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/jhg.2010.6","volume":"55","author":"SJ LEE","year":"2010","unstructured":"LEE SJ, Kim WY, Choi JY, et al. Identification of CYP19A1 single-nucleotide polymorphisms and their haplotype distributions in a Korean population. J Hum Genet. 2010;55(3):189\u201393.","journal-title":"J Hum Genet"},{"key":"2115_CR42","doi-asserted-by":"crossref","unstructured":"Umamaheswaran G, Kadambari D, Kumar AS, et al. Polymorphic genetic variations of cytochrome P450 19A1 and T-cell leukemia 1A genes in the Tamil population. Volume 39. ENVIRON TOXICOL PHAR; 2015. pp. 102\u201313. 1.","DOI":"10.1016\/j.etap.2014.10.022"},{"issue":"3","key":"2115_CR43","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s12032-013-0665-x","volume":"30","author":"G Umamaheswaran","year":"2013","unstructured":"Umamaheswaran G, Dkhar SA, Kalaivani S, et al. Haplotype structures and functional polymorphic variants of the drug target enzyme aromatase (CYP19A1) in South Indian population. MED ONCOL. 2013;30(3):665.","journal-title":"MED ONCOL"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-025-02115-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12920-025-02115-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-025-02115-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T12:07:32Z","timestamp":1741608452000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenomics.biomedcentral.com\/articles\/10.1186\/s12920-025-02115-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,10]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2115"],"URL":"https:\/\/doi.org\/10.1186\/s12920-025-02115-6","relation":{},"ISSN":["1755-8794"],"issn-type":[{"type":"electronic","value":"1755-8794"}],"subject":[],"published":{"date-parts":[[2025,3,10]]},"assertion":[{"value":"3 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Our study was approved by the Institutional Ethics Committee of the Fourth Hospital of Hebei Medical University, and informed consent was obtained from all enrolled participants before the study was conducted. The study was conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"43"}}